Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the launch of the Guardant ...

In arm 1 of the trial, the dose-escalation portion, patients will receive mRNA-4106 at a test dose as monotherapy. In arm 2, ...

Q1 2025 Earnings Call Transcript May 19, 2025 Compugen Ltd. misses on earnings expectations. Reported EPS is $-0.08 EPS, ...

Diane Kraus dedicated the last years of her life to advocating for medical aid in dying. Her own death was everything she ...

First-generation GLP-1 drugs have found to cut down the risk of obesity-related cancers by 41%, outperforming weight-loss ...

Up to half of women have fibroid tumors and many don't realize it. While these growths in the uterus are common, they can ...